Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Acquisition Completion Update

31st Aug 2012 13:23

RNS Number : 2350L
United Drug PLC
31 August 2012
 



United Drug plc

Acquisition Completion Update

 

UDG.I UDG.L

 

 

31 August 2012: Further to the announcement issued by United Drug plc ("UD" or "the Group") on 20 August 2012, the Group confirms the completion of the acquisition of the UK and US clinical services businesses (combined "Bilcare Global Clinical Supplies" or "Bilcare GCS") from Bilcare Limited.

 

Further to the announcement issued by UD on 26 July 2012, the Group advises that the acquisition of the entire issued share capital of Pharmexx GmbH ("Pharmexx") is now expected to complete over the coming weeks.

 

ENDS

 

 

For reference:

 

Liam FitzGerald

Pauline McAlester

Greg Lawless/Lisa Kavanagh

Barry Mc Grane

Irish media

UK media

United Drug plc

Murray Consultants

Powerscourt

Tel: +353-1-4632300

Tel: +353-1-4980300

Tel: +44 207 250 1446

 

 

About United Drug plc

 

Listed on the Stock Exchanges in London and Dublin, United Drug is a leading international provider of services to healthcare manufacturers and pharmaceutical retailers, with operations in over 20 countries including: the UK, Ireland, Germany, the Netherlands, Belgium, and the USA. 

 

The Company operates across three divisions, Healthcare Supply Chain, Sales, Marketing & Medical, and Packaging & Specialty.

 

In Healthcare Supply Chain, United Drug is the largest pharmaceutical wholesaler in the island of Ireland. It is also the market leader in contract distribution outsourcing (pre-wholesaling) in Ireland and has achieved the No. 1 position in the UK through its joint venture business UniDrug Distribution Group (UDG). The Company provides specials medicines manufacturing and distribution services in the UK. Through its medical & scientific operations, United Drug provides sales & marketing and technical service solutions, including contract distribution services to a wide range of medical & scientific equipment & consumable manufacturers, with a market leading position in Ireland and an emerging presence in the UK.

 

In the Sales, Marketing & Medical division United Drug is a global leader in the provision of contract sales outsourcing services to pharmaceutical manufacturers with operations in major markets including Continental Europe, the UK, North America and a presence in South America. United Drug also provides related marketing services to pharmaceutical manufacturers in many of these markets.

 

In the Packaging & Specialty division United Drug is a leading international provider of pharmaceutical contract packaging and clinical trials materials services with facilities in the US, UK, Dutch and Belgian markets. The Company also provides speciality distribution and homecare services in the UK and Ireland.

 

For more information go to www.united-drug.com. 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFFTFILVIF

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00